Related content

The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate

By Oostendorp Roos   Marchetti Serena   Beijnen Jos   Mazzanti R.   Schellens Jan  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 855-860

Springer Publishing Company

Access to resources Recommend Favorite

Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1171-1175

Spandidos Publications

Access to resources Recommend Favorite

The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects

By Hamilton Marta   Wolf Julie   Drolet Daniel   Fettner Scott   Rakhit Ashok   Witt Karsten   Lum Bert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 613-621

Springer Publishing Company

Access to resources Recommend Favorite

Dexamethasone as a probe for docetaxel clearance

By Puisset Florent   Chatelut Etienne   Dalenc Florence   Busi Florent   Cresteil Thierry   Azéma Joëlle   Poublanc Muriel   Hennebelle Isabelle   Lafont Thierry   Chevreau Christine   Roché Henri  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of CYP3A5 attenuates inducibility and activity of CYP3A4 in HepG2 cells

By            

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2868-2874

Spandidos Publications

Access to resources Recommend Favorite